TrialBreast cancer research and treatment2025

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108.

Vered Stearns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.